{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T08:45:40Z","timestamp":1792485940724,"version":"4.5.0"},"reference-count":124,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100016331","name":"Huanghuai University","doi-asserted-by":"publisher","award":["2025411701000008"],"award-info":[{"award-number":["2025411701000008"]}],"id":[{"id":"10.13039\/501100016331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016331","name":"Huanghuai University","doi-asserted-by":"publisher","award":["2023411701000107"],"award-info":[{"award-number":["2023411701000107"]}],"id":[{"id":"10.13039\/501100016331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016331","name":"Huanghuai University","doi-asserted-by":"publisher","award":["12011853"],"award-info":[{"award-number":["12011853"]}],"id":[{"id":"10.13039\/501100016331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejmech.2025.118449","type":"journal-article","created":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T23:03:02Z","timestamp":1764543782000},"page":"118449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Indole hybrids: Emerging therapeutic candidates for breast cancer (2023\u20132025)"],"prefix":"10.1016","volume":"303","author":[{"given":"Shanshan","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8877-1392","authenticated-orcid":false,"given":"Zhi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejmech.2025.118449_bib1","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","article-title":"Global patterns and trends in breast cancer incidence and mortality across 185 countries","volume":"31","author":"Kim","year":"2025","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118449_bib2","doi-asserted-by":"crossref","first-page":"649","DOI":"10.32604\/oncologie.2022.027640","article-title":"Epidemiology of breast cancer","volume":"24","author":"Shang","year":"2022","journal-title":"Oncol."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118449_bib3","first-page":"42","article-title":"Breast cancer","volume":"51","author":"Satherley","year":"2023","journal-title":"Medicine (United Kingdom)"},{"issue":"10286","key":"10.1016\/j.ejmech.2025.118449_bib4","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/S0140-6736(20)32381-3","article-title":"Breast cancer","volume":"397","author":"Loibl","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ejmech.2025.118449_bib5","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2025.118449_bib6","first-page":"524","article-title":"Breast cancer statistics, 2022","volume":"72","author":"Giaquinto","year":"2022","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.ejmech.2025.118449_bib7","first-page":"287","article-title":"Global burden of female breast cancer: new estimates in 2022, temporal trend and future projections up to 2050 based on the latest release from GLOBOCAN","volume":"5","author":"Zhang","year":"2025","journal-title":"J. Natl. Cancer Cent."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118449_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(25)00136-6","article-title":"Projected global rise in breast cancer incidence and mortality by 2050","volume":"26","author":"Devi","year":"2025","journal-title":"Lancet Oncol."},{"issue":"7","key":"10.1016\/j.ejmech.2025.118449_bib9","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1007\/s00044-024-03241-z","article-title":"Unlocking therapeutic potential: exploring indole scaffolds and their structural insights as pharmacophores in designing anti-breast cancer agents","volume":"33","author":"Vinod","year":"2024","journal-title":"Med. Chem. Res."},{"issue":"6","key":"10.1016\/j.ejmech.2025.118449_bib10","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2174\/0115701786351199241112163708","article-title":"Indole derivatives: versatile scaffolds in drug development and cancer therapeutics","volume":"22","author":"Kulyal","year":"2025","journal-title":"Lett. Org. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2025.118449_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202300402","article-title":"The anti-breast cancer potential of indole\/isatin hybrids","volume":"356","author":"Wang","year":"2023","journal-title":"Arch. Pharm."},{"issue":"12","key":"10.1016\/j.ejmech.2025.118449_bib12","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1080\/17568919.2025.2521250","article-title":"The current landscape of indole hybrids with in vivo antitumor potential","volume":"17","author":"He","year":"2025","journal-title":"Future Med. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2025.118449_bib13","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1080\/17568919.2025.2485675","article-title":"Development of indole hybrids for potential lung cancer treatment-part I: nitrogen-containing six-membered aromatic heterocycles","volume":"17","author":"Zhao","year":"2025","journal-title":"Future Med. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2025.118449_bib14","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1080\/17568919.2025.2485867","article-title":"Development of indole hybrids for potential lung cancer treatment-part II","volume":"17","author":"Huang","year":"2025","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib15","doi-asserted-by":"crossref","first-page":"15847","DOI":"10.1021\/acs.jmedchem.3c01336","article-title":"Discovery of 5-(Pyrimidin-2-ylamino)-1H-indole-2-carboxamide derivatives as Nur77 modulators with selective and potent activity against triple-negative breast cancer","volume":"66","author":"Qin","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108577","article-title":"Design, synthesis, and biological evaluation of N-(2-amino-phenyl)-5-(4-aryl- pyrimidin-2-yl) amino)-1H-indole-2-carboxamide derivatives as novel inhibitors of CDK9 and class I HDACs for cancer treatment","volume":"162","author":"Chen","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115284","article-title":"Design, synthesis, and biological evaluation of diaryl heterocyclic derivatives targeting tubulin polymerization with potent anticancer activities","volume":"252","author":"Li","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116711","article-title":"Novel EGFR inhibitors against resistant L858R\/T790M\/C797S mutant for intervention of non-small cell lung cancer","volume":"277","author":"Wang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib19","doi-asserted-by":"crossref","first-page":"11188","DOI":"10.1021\/acs.jmedchem.5c00189","article-title":"Optimization of 1-Methyl-3-(pyridin-3-yl)-1H-indol derivatives as ROR1 inhibitors with improved activity and selectivity","volume":"68","author":"Zheng","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117057","article-title":"Design, synthesis and anti-tumor evaluation of novel pyrimidine and quinazoline analogues","volume":"282","author":"Lin","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117059","article-title":"Discovery of a potent anticancer agent against pancreatic ductal adenocarcinoma targeting FAK with DFG-out state and JAK\/Aurora kinases","volume":"282","author":"Zhang","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107390","article-title":"Design, synthesis, and evaluation of antitumor activity of mobocertinib derivatives, a third-generation EGFR inhibitor","volume":"147","author":"Fan","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202300736","article-title":"Rational design and synthesis of 2,4-dichloro-6-methyl pyrimidine derivatives as potential selective EGFRT790M\/L858R inhibitors for the treatment of non-small cell lung cancer","volume":"357","author":"Duan","year":"2024","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2025.118449_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1074576","article-title":"Pharmacokinetics, tissue distribution, and antitumor activity of a novel compound, NY-2, in non-small cell lung cancer","volume":"13","author":"Zhang","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118449_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117314","article-title":"Discovery of novel thienopyridine indole derivatives as inhibitors of tubulin polymerization targeting the colchicine-binding site with potent anticancer activities","volume":"286","author":"Liu","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116791","article-title":"Discovery of novel thiophene[3,2-d]pyrimidine-based tubulin inhibitors with enhanced antitumor efficacy for combined use with anti-pd-l1 immunotherapy in melanoma","volume":"277","author":"Xu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115955","article-title":"Discovery and optimization of thieno[3,2-d]pyrimidine derivatives as highly selective inhibitors of cyclin-dependent kinase 7","volume":"263","author":"Zhang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107456","article-title":"Design, synthesis and evaluation of thieno[3,2-d]pyrimidine derivatives as novel potent CDK7 inhibitors","volume":"148","author":"Zhang","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116395","article-title":"Design, synthesis and evaluation of a pyrazolo[3,4-d]pyrimidine derivative as a novel and potent TGF\u03b21R1 inhibitor","volume":"271","author":"Wang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114945","article-title":"Discovery of novel 7,7-dimethyl-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidines as ATR inhibitors based on structure-based drug design","volume":"246","author":"Qi","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107237","article-title":"Discovery of the 2,4-disubstituted quinazoline derivative as a novel neddylation inhibitor for tumor therapy","volume":"145","author":"Su","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28145348","article-title":"The synthesis and biological evaluation of 2-(1H-Indol-3-yl)quinazolin-4(3H)-One derivatives","volume":"28","author":"Mendogralo","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118449_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2024.117799","article-title":"Rutaecarpine-inspired scaffold-hopping strategy and Ullmann cross-coupling based synthetic approach: identification of pyridopyrimidinone-indole based novel anticancer chemotypes","volume":"109","author":"Yadav","year":"2024","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib34","article-title":"Synthesis and anticancer evaluation of benzylated indole based alkyl-substituted Pyrido[2,3-d]Pyrimidines targeting thymidylate synthase","volume":"9","author":"Kumar","year":"2024","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2025.118449_bib35","doi-asserted-by":"crossref","first-page":"4868","DOI":"10.1021\/acs.jmedchem.2c02036","article-title":"Novel Indole-chalcone derivative-ligated Platinum(IV) prodrugs attenuate cisplatin resistance in lung cancer through ROS\/ER stress and mitochondrial dysfunction","volume":"66","author":"Liu","year":"2023","journal-title":"J. Med. Chem."},{"issue":"18","key":"10.1016\/j.ejmech.2025.118449_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28186583","article-title":"Design, synthesis, and evaluation of novel indole hybrid chalcones and their antiproliferative and antioxidant activity","volume":"28","author":"Kudli\u010dkov\u00e1","year":"2023","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118449_bib37","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.3390\/ph17010032","article-title":"Synthesis and Biological Evaluation of Chalconesulfonamides: en Route to Proapoptotic Agents with Antiestrogenic Potency","volume":"17","author":"Krymov","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"12","key":"10.1016\/j.ejmech.2025.118449_bib38","doi-asserted-by":"crossref","first-page":"7903","DOI":"10.1007\/s11696-023-03060-3","article-title":"Design, synthesis, and assessment of pharmacological properties of indole-based fluorinated chalcones and their benzenesulfonamide analogs","volume":"77","author":"Yamali","year":"2023","journal-title":"Chem. Pap."},{"issue":"9","key":"10.1016\/j.ejmech.2025.118449_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202300562","article-title":"Design, synthesis, and antiproliferative activity of new indole\/1,2,4-triazole\/chalcone hybrids as EGFR and\/or c-MET inhibitors","volume":"357","author":"Mahmoud","year":"2024","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2025.118449_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117058","article-title":"Biological evaluation and mechanism study of a novel indole-pyridine chalcone derivative as antiproliferative agent against tumor cells through dual targeting tubulin and HK2","volume":"282","author":"Zheng","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2024.117778","article-title":"Efficient synthesis of indole-chalcones based glycohybrids and their anticancer activity","volume":"109","author":"Tyagi","year":"2024","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116061","article-title":"Design, synthesis, and biological evaluation of harmine derivatives as topoisomerase I inhibitors for cancer treatment","volume":"265","author":"Guo","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26115396","article-title":"Antitumor activity of Tetrahydro-\u03b2-carboline derivatives via inhibition of kinesin spindle protein: validation by molecular docking, molecular dynamics, and in vitro assays","volume":"26","author":"Guo","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.118449_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.jics.2024.101404","article-title":"Indole analogs as potential anti-breast cancer agents: design, synthesis, in-vitro bioevaluation with DFT, molecular docking and ADMET studies","volume":"101","author":"Gavadia","year":"2024","journal-title":"J. Indian Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.118449_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.70008","article-title":"Design, synthesis, and evaluation of novel indole-based small molecules as sirtuin inhibitors with anticancer activities","volume":"85","author":"Binarci","year":"2024","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejmech.2025.118449_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914656","article-title":"Design, synthesis, and potent anticancer activity of novel indole-based Bcl-2 inhibitors","volume":"24","author":"Almehdi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.118449_bib47","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1039\/D3MD00524K","article-title":"Novel indolyl 1,2,4-triazole derivatives as potential anti-proliferative agents: in silico studies, synthesis, and biological evaluation","volume":"15","author":"Ghobish","year":"2024","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108677","article-title":"Design, synthesis, and molecular modeling of new 1,2,4-triazole-containing indole compounds as aromatase antagonists for the treatment of breast cancer","volume":"163","author":"Elrashedy","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/ph18020275","article-title":"Design, synthesis, and antiproliferative activity of novel Indole\/1,2,4-Triazole hybrids as tubulin polymerization inhibitors","volume":"18","author":"Mahmoud","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2025.118449_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108677","article-title":"Design, synthesis, and molecular modeling of new 1,2,4-triazole-containing indole compounds as aromatase antagonists for the treatment of breast cancer","volume":"163","author":"Elrashedy","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib51","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202405930","article-title":"Design and synthesis of some new Indole-piperazine-1,2,3-triazole conjugates; in vitro anticancer, molecular docking, and ADMET studies","volume":"10","author":"Lingaswamy","year":"2025","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2025.118449_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2024.101536","article-title":"An efficient synthesis and anticancer evaluation of 1,2,3-triazolo-indole-2-carboxylate derivatives","volume":"7","author":"Anantoju","year":"2024","journal-title":"Results Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.134415","article-title":"Design of new hybrids indole\/phthalimide\/oxadiazole-1,2,3 triazole agents and their anticancer properties","volume":"1274","author":"Mohamed","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.118449_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107341","article-title":"Design, synthesis, in silico and biological evaluation of new indole based oxadiazole derivatives targeting estrogen receptor alpha","volume":"147","author":"Kaur","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.141176","article-title":"Anti-breast cancer potential of new indole derivatives: synthesis, in-silico study, and cytotoxicity evaluation on MCF-7 cells","volume":"1326","author":"Abood","year":"2025","journal-title":"J. Mol. Struct."},{"issue":"6","key":"10.1016\/j.ejmech.2025.118449_bib56","doi-asserted-by":"crossref","first-page":"517","DOI":"10.4155\/fmc-2023-0012","article-title":"Pyrimido[4,5-b]indole derivatives bearing 1,2,4-oxadiazole moiety as MDM2 inhibitor candidates in cancer treatment","volume":"15","author":"Mehri","year":"2023","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib57","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1021\/acsptsci.5c00103","article-title":"Discovery of anticancer indole-based 4,5-Dihydroisoxazole derivative with selectivity toward leukemia cells","volume":"8","author":"Majirsk\u00e1","year":"2025","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.ejmech.2025.118449_bib58","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1039\/D3MD00730H","article-title":"Design, synthesis, in vitro and in silico evaluation of indole-based tetrazole derivatives as putative anti-breast cancer agents","volume":"15","author":"Kuar","year":"2024","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2024.130070","article-title":"Development of 3-indolyl substituted phenyl pyrazolo-carboxamide hybrids as potential type II VEGFR-2 inhibitors and in vitro cytotoxicity studies","volume":"117","author":"Valapil","year":"2025","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118449_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.135477","article-title":"Novel indole-pyrazole hybrids as potential tubulin-targeting agents; Synthesis, antiproliferative evaluation, and molecular modeling studies","volume":"1285","author":"Hawash","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.118449_bib61","article-title":"Synthesis, anti-tumor evaluation, and mechanistic investigation of 3-indolylpyrazole phenoxyacetamide derivatives against chronic myeloid leukemia cells","author":"Liu","year":"2025","journal-title":"Mol. Divers."},{"key":"10.1016\/j.ejmech.2025.118449_bib62","article-title":"Design, synthesis, and bioactivity evaluation of novel indole-selenide derivatives as P-glycoprotein inhibitors against multi-drug resistance in MCF-7\/ADR cell","volume":"263","author":"Yang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2025.102074","article-title":"Synthesis, biological evaluation, molecular docking, and DFT calculation of novel 4-(1H-indol-3-yl)-3-methyl-1-phenyl-1H-furo[2,3-c]pyrazole derivatives","volume":"14","author":"Nassiri","year":"2025","journal-title":"Results Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2025.118449_bib64","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202300185","article-title":"Synthesis and SARs study of novel spiro-oxindoles as potent antiproliferative agents with CDK-2 inhibitory activities","volume":"356","author":"Al-Jassas","year":"2023","journal-title":"Arch. Pharm."},{"issue":"5","key":"10.1016\/j.ejmech.2025.118449_bib65","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202400817","article-title":"New indole-based Phenylthiazolyl-2,4-dihydropyrazolones as tubulin polymerization inhibitors: multicomponent synthesis, cytotoxicity evaluation, and in silico studies","volume":"20","author":"Bakchi","year":"2025","journal-title":"ChemMedChem"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118449_bib66","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2025.2516075","article-title":"Design, synthesis, and antiproliferative activity of new 5-ethylsulfonyl-indazole-3-carbohydrazides as dual EGFR\/VEGFR-2 kinases inhibitors","volume":"40","author":"Al-Wahaibi","year":"2025","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"13","key":"10.1016\/j.ejmech.2025.118449_bib67","doi-asserted-by":"crossref","first-page":"10655","DOI":"10.1021\/acs.jmedchem.4c00175","article-title":"Discovery of novel receptor tyrosine kinase-like orphan receptor 1 (ROR1) inhibitors for cancer treatment","volume":"67","author":"Luo","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.137343","article-title":"Synthesis, biological evaluation and molecular docking of thiazole hydrazone derivatives grafted with indole as novel tubulin polymerization inhibitors","volume":"1301","author":"Wang","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.118449_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.134013","article-title":"Novel series of N-acyl substituted indole based piperazine, thiazole and tetrazoles as potential antibacterial, antifungal, antioxidant and cytotoxic agents, and their docking investigation as potential Mcl-1 inhibitors","volume":"1271","author":"Jagadeesan","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.118449_bib70","doi-asserted-by":"crossref","first-page":"41944","DOI":"10.1021\/acsomega.4c06889","article-title":"Synthesis and evaluation of Thiazolyl-indole-2-carboxamide derivatives as potent multitarget anticancer agents","volume":"9","author":"Saadan","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2025.118449_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.142089","article-title":"New benzothiazole-indole-1,2,3-triazole-N-phenylacetamide derivatives as cytotoxic agents: design, synthesis, and in vitro cytotoxic evaluations","volume":"1336","author":"Taherkhani","year":"2025","journal-title":"J. Mol. Struct."},{"issue":"37","key":"10.1016\/j.ejmech.2025.118449_bib72","doi-asserted-by":"crossref","first-page":"34044","DOI":"10.1021\/acsomega.3c05038","article-title":"Synthesis, biological evaluation, and molecular docking of novel azolylhydrazonothiazoles as potential anticancer agents","volume":"8","author":"Al-Humaidi","year":"2023","journal-title":"ACS Omega"},{"issue":"15","key":"10.1016\/j.ejmech.2025.118449_bib73","doi-asserted-by":"crossref","first-page":"13363","DOI":"10.1021\/acs.jmedchem.4c01255","article-title":"Targeting hTERT promoter G-Quadruplex DNA structures with small-molecule ligand to downregulate hTERT expression for triple-negative breast cancer therapy","volume":"67","author":"Long","year":"2024","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118449_bib74","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202302000","article-title":"Synthesis of indole-linked thiadiazoles and their anticancer action against triple-negative breast cancer","volume":"21","author":"Gavadia","year":"2024","journal-title":"Chem. Biodiversity"},{"key":"10.1016\/j.ejmech.2025.118449_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115193","article-title":"Design, synthesis, and discovery of Eudistomin Y derivatives as lysosome-targeted antiproliferation agents","volume":"250","author":"Yang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"24","key":"10.1016\/j.ejmech.2025.118449_bib76","doi-asserted-by":"crossref","first-page":"21975","DOI":"10.1021\/acs.jmedchem.4c01921","article-title":"Structure-guided discovery of subtype selective SIRT6 inhibitors with a \u03b2-Carboline skeleton for the treatment of breast cancer","volume":"67","author":"Liang","year":"2024","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118449_bib77","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11030-024-10840-w","article-title":"Design, synthesis and biological evaluation of 5H-[1,2,4]triazino[5,6-b]indole derivatives bearing a pyridinocycloalkyl moiety as iron chelators","volume":"29","author":"Li","year":"2025","journal-title":"Mol. Divers."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118449_bib78","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1021\/acs.jmedchem.2c01612","article-title":"Indole derivatives as new structural class of potent and antiproliferative inhibitors of monocarboxylate transporter 1 (MCT1; SLC16A1)","volume":"66","author":"Puri","year":"2023","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2025.118449_bib79","doi-asserted-by":"crossref","first-page":"6968","DOI":"10.1021\/acsomega.2c07793","article-title":"Vanillin-based Indolin-2-one derivative bearing a pyridyl moiety as a promising anti-breast cancer agent via anti-estrogenic activity","volume":"8","author":"Bender","year":"2023","journal-title":"ACS Omega"},{"issue":"13","key":"10.1016\/j.ejmech.2025.118449_bib80","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241311093","article-title":"Novel tetrazole derivatives targeting tubulin endowed with antiproliferative activity against glioblastoma cells","volume":"24","author":"Gallego-Yerga","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.118449_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2025.130132","article-title":"Zirconium oxide nano-catalyzed bis(indolyl)methanes: a sustainable route to anticancer therapies","volume":"120","author":"Rathi","year":"2025","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"27","key":"10.1016\/j.ejmech.2025.118449_bib82","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202401002","article-title":"Development of novel pyridine and pyrimidine clubbed bisindoles as inhibitors of AKT pathway","volume":"9","author":"Poonacha","year":"2024","journal-title":"ChemistrySelect"},{"issue":"8","key":"10.1016\/j.ejmech.2025.118449_bib83","doi-asserted-by":"crossref","first-page":"5550","DOI":"10.1021\/acs.jmedchem.2c01999","article-title":"Novel benzo five-membered heterocycle derivatives as P-Glycoprotein inhibitors: design, synthesis, molecular docking, and anti-multidrug resistance activity","volume":"66","author":"Yang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115092","article-title":"Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7\/ADR cell","volume":"248","author":"Yang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115625","article-title":"Discovery of tetrahydroisoquinolineindole derivatives as first dual PRMT5 inhibitors\/hnRNP E1 upregulators: design, synthesis and biological evaluation","volume":"258","author":"Chu","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115881","article-title":"Design, synthesis and biological evaluation of novel dihydroquinolin-4(1H)-one derivatives as novel tubulin polymerization inhibitors","volume":"262","author":"Tan","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116869","article-title":"Discovery and biological evaluation of 6-aryl-4-(3,4,5-trimethoxyphenyl)quinoline derivatives with promising antitumor activities as novel colchicine-binding site inhibitors","volume":"279","author":"Xu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107942","article-title":"Potochemical metal-free synthesis and biological assessment of isocryptolepine analogues targeting estrogen receptor alpha in breast cancer cells","volume":"153","author":"Bogdanov","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2024.129710","article-title":"Design, synthesis, and biological evaluation of novel benzo[6,7]indolo[3,4-c]isoquinolines as anticancer agents with topoisomerase I inhibition","volume":"104","author":"Sakai","year":"2024","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118449_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.136001","article-title":"Design, synthesis and in vitro cytotoxic evaluation of \u03b2-carboline tethered quinoline-4-carboxamide conjugates as DNA-interactive Topo II inhibitors","volume":"1291","author":"Soni","year":"2023","journal-title":"J. Mol. Struct."},{"issue":"17","key":"10.1016\/j.ejmech.2025.118449_bib91","doi-asserted-by":"crossref","first-page":"12832","DOI":"10.1021\/acs.joc.4c01441","article-title":"One-pot total synthesis of natural products nitramarine, nitraridine, and analogues via a Cascade Oxidation\/pictet-spengler condensation\/annulation process","volume":"89","author":"Song","year":"2024","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2024.117734","article-title":"Discovery of harmiprims, harmine-primaquine hybrids, as potent and selective anticancer and antimalarial compounds","volume":"105","author":"Pavi\u0107","year":"2024","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115274","article-title":"Antitumor effect of 3-(quinolin-2-ylmethylene)-4,6-dimethyl-5-hydroxy-7-azaoxindole down-regulating the Gas6-Axl axis","volume":"251","author":"Bae","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106900","article-title":"Synthesis of 3-sulfenylindole derivatives from 4-hydroxy-2H-chromene-2-thione and indole using oxidative cross-dehydrogenative coupling reaction and anti-proliferative activity study of some of their sulfone derivatives","volume":"141","author":"Xalxo","year":"2023","journal-title":"Bioorg. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2025.118449_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24097724","article-title":"Chemical and biological evaluation of novel 1H-Chromeno[3,2-c]pyridine derivatives as MAO inhibitors endowed with potential anticancer activity","volume":"24","author":"Kulikova","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.ejmech.2025.118449_bib96","doi-asserted-by":"crossref","DOI":"10.3390\/ph16030333","article-title":"Novel indole-tethered chromene derivatives: synthesis, cytotoxic properties, and key computational insights","volume":"16","author":"Malik","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"3","key":"10.1016\/j.ejmech.2025.118449_bib97","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28031481","article-title":"Novel indole-containing hybrids derived from millepachine: synthesis, biological evaluation and antitumor mechanism study","volume":"28","author":"Liang","year":"2023","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.ejmech.2025.118449_bib98","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.5530\/pj.2023.15.201","article-title":"Novel coumarin-indole hybrids as cytotoxic candidates: synthesis and antiproliferative activity","volume":"15","author":"Ismael","year":"2023","journal-title":"Pharmacog. J."},{"issue":"7","key":"10.1016\/j.ejmech.2025.118449_bib99","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.70060","article-title":"Design, synthesis, and biological evaluation of triazole tethered coumarin-indole fused chalcone-isatin derivatives as a new class of anti-breast cancer agents","volume":"358","author":"Uppal","year":"2025","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2025.118449_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115776","article-title":"Tetrahydro-\u03b2-carboline derivatives as potent histone deacetylase 6 inhibitors with broad-spectrum antiproliferative activity","volume":"260","author":"Chen","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108454","article-title":"Unlocking the potential of novel tetrahydro-\u03b2-carboline-based HDAC6 inhibitors for colorectal cancer therapy: design, synthesis and biological evaluation","volume":"160","author":"Hemida","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2025.118449_bib102","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00706-025-03336-2","article-title":"Development of tetrahydro-\u03b3-carboline-based histone deacetylase inhibitors with antitumor activities","volume":"156","author":"Wan","year":"2025","journal-title":"Monatsh. Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115303","article-title":"Design, synthesis and biological evaluation of dual topo II\/HDAC inhibitors bearing pyrimido[5,4-b]indole and pyrazolo[3,4-d]pyrimidine motifs","volume":"252","author":"Zhao","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118449_bib104","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1021\/acs.jmedchem.2c01191","article-title":"BET-HDAC dual inhibitors for combinational treatment of breast cancer and concurrent candidiasis","volume":"66","author":"Huang","year":"2023","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118449_bib105","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2201408","article-title":"Discovery of novel benzohydroxamate-based histone deacetylase 6 (HDAC6) inhibitors with the ability to potentiate anti-PD-L1 immunotherapy in melanoma","volume":"38","author":"Peng","year":"2023","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"22","key":"10.1016\/j.ejmech.2025.118449_bib106","doi-asserted-by":"crossref","first-page":"20172","DOI":"10.1021\/acs.jmedchem.4c01524","article-title":"Discovery of novel 5-Cyano-3-phenylindole-Based LSD1\/HDAC dual inhibitors for colorectal cancer treatment","volume":"67","author":"Zhu","year":"2024","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2025.118449_bib107","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202300149","article-title":"Melatonin-vorinostat hybrid ligands show higher histone deacetylase and cancer cell growth inhibition than vorinostat","volume":"356","author":"Helmi","year":"2023","journal-title":"Arch. Pharm."},{"issue":"23","key":"10.1016\/j.ejmech.2025.118449_bib108","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202300281","article-title":"Discovery of a dual-target inhibitor of CDK7 and HDAC1 that induces apoptosis and inhibits migration in colorectal cancer","volume":"18","author":"Chen","year":"2023","journal-title":"ChemMedChem"},{"issue":"5","key":"10.1016\/j.ejmech.2025.118449_bib109","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1039\/D4MD00898G","article-title":"Synthesis of fluorinated tubastatin A derivatives with bi-, tri-, and tetracyclic cap groups: molecular docking with HDAC6 and evaluation of in vitro antitumor activity","volume":"16","author":"Luo","year":"2025","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2025.118094","article-title":"Discovery of 3-indolylbenzoquinone derivatives with therapeutic potential for breast cancer","volume":"120","author":"Hu","year":"2025","journal-title":"Bioorg. Med. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2025.118449_bib111","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26125903","article-title":"Exploring carboxamide derivatives as promising anticancer agents: design, in vitro evaluation, and mechanistic insights","volume":"26","author":"Al-Najdawi","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.118449_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108401","article-title":"Optimizing ST6GAL1 inhibition and selectivity using lithocholic acid-amino acid conjugates for antimetastatic and antiangiogenic agent development","volume":"159","author":"Chen","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"18","key":"10.1016\/j.ejmech.2025.118449_bib113","doi-asserted-by":"crossref","first-page":"19415","DOI":"10.1021\/acs.jmedchem.5c01594","article-title":"Design, synthesis and biological evaluation of 7-(1-Methyl-1H-indole-3-yl)-5H-pyrrolo[2,3-b]pyrazine derivatives as novel covalent pan-FGFR inhibitors to overcome clinical resistance","volume":"68","author":"Deng","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib114","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2024.1432920","article-title":"Design and synthesis new indole-based aromatase\/iNOS inhibitors with apoptotic antiproliferative activity","volume":"12","author":"Al-Wahaibi","year":"2024","journal-title":"Front. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2025.118449_bib115","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1007\/s00044-023-03152-5","article-title":"New indolo-\u03b2-lactam hybrids as potential anticancer and anti-inflammatory agents","volume":"32","author":"Ghaffari","year":"2023","journal-title":"Med. Chem. Res."},{"issue":"14","key":"10.1016\/j.ejmech.2025.118449_bib116","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202405314","article-title":"Anti-inflammatory and anticancer activities of new monocyclic indolo \u03b2-Lactam hybrids","volume":"10","author":"Ghaffari","year":"2025","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2025.118449_bib117","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.31635\/ccschem.024.202404224","article-title":"Cooperative catalysis-enabled Cascade allylation\/aza-Prins cyclization to chiral Spiroindolylpiperidine-\u03b3-Butyrolactones","volume":"7","author":"Xiao","year":"2025","journal-title":"CCC Chem"},{"key":"10.1016\/j.ejmech.2025.118449_bib118","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1021\/acs.jmedchem.3c01508","article-title":"Selective antitumor effect and lower toxicity of Mitochondrion- targeting derivatization of triptolide","volume":"67","author":"Xing","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib119","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.1021\/acs.jmedchem.4c02116","article-title":"Novel Indoleamine-2,3-Dioxygenase-Targeted Pt(IV) prodrugs regulate the tumor immune microenvironment to achieve chemoimmunotherapy in vitro and in vivo","volume":"68","author":"Li","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101252","article-title":"A novel platinum(IV) prodrug, gramine-Pt(IV) enhances chemoimmunotherapy by activating cGAS-STING and modulating TGF-\u03b2-MHC-I axis","volume":"81","author":"Ding","year":"2025","journal-title":"Drug Resist. Updates"},{"issue":"2","key":"10.1016\/j.ejmech.2025.118449_bib121","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202300467","article-title":"Exploring derivatives of quinolizidine alkaloid sophoridine in the design and biological mechanistic evaluation of histone deacetylase inhibitors against triple-negative breast cancer","volume":"19","author":"Dai","year":"2024","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.118449_bib122","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.1078163","article-title":"Pyrazolyl-s-triazine with indole motif as a novel of epidermal growth factor receptor\/cyclin-dependent kinase 2 dual inhibitors","volume":"10","author":"Shawish","year":"2022","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejmech.2025.118449_bib123","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1039\/D5MD00297D","article-title":"Design, synthesis and biological evaluation of novel bis(indolyl)-tetrazine derivatives as antibreast cancer agents","volume":"16","author":"Kaur","year":"2025","journal-title":"RSC Med. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2025.118449_bib124","doi-asserted-by":"crossref","DOI":"10.3390\/ph18081231","article-title":"Novel indole-based sulfonylhydrazones as potential anti-breast cancer agents: synthesis, in vitro evaluation, ADME, and QSAR studies","volume":"18","author":"Angelova","year":"2025","journal-title":"Pharmaceuticals"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425012140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425012140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:52:16Z","timestamp":1781326336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425012140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":124,"alternative-id":["S0223523425012140"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118449","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Indole hybrids: Emerging therapeutic candidates for breast cancer (2023\u20132025)","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118449","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118449"}}